Search research articles
Contact Us
Filters
Showing results (81-90 of 625) with videos related to
Page
of 63
Sort By:
CNS Spectrums
|
August 26, 2004
Augmentation strategies in the treatment of schizophrenia
D C Goff, O Freudenreich, A E Evins
Expert Review of Neurotherapeutics
|
July 6, 2007
Inflammation and schizophrenia
Xiaoduo Fan, Donald C Goff, David C Henderson
Early Intervention in Psychiatry
|
March 1, 2011
Initial medical work-up of first-episode psychosis: a conceptual review
Oliver Freudenreich, S Charles Schulz, Donald C Goff
The New England Journal of Medicine
|
April 7, 2007
Biomarkers for prediction of cardiovascular events
Diane M Becker, Samia Mora, David C Goff
Current Drug Targets. CNS and Neurological Disorders
|
May 29, 2003
Ionotropic glutamate receptors as therapeutic targets in schizophrenia
Joseph T Coyle, Guochuan Tsai, Donald C Goff
Future Cardiology
|
November 6, 2009
Atrial fibrillation and ethnicity: the known, the unknown and the paradox
Elsayed Z Soliman, Alvaro Alonso, David C Goff
North Carolina Medical Journal
|
April 27, 2013
30,000 fewer heart attacks and strokes in North Carolina: a challenge to prioritize prevention
Alain G Bertoni, Don Ensley, David C Goff
Journal of the American College of Cardiology
|
October 8, 2021
On-Treatment Hypertension Control in a Real-World Cohort: Lower Blood Pressure Remains Better
S Andrew McCullough, David C Goff, Peter M Okin
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1981
Mutation in an intervening sequence splice junction in man
S H Orkin, S C Goff, R L Hechtman
Psychopharmacology
|
July 8, 2005
The potential role of lamotrigine in schizophrenia
Charles H Large, Elizabeth L Webster, Donald C Goff
Page
of 63
Search research articles
Search
Showing results (81-90 of 625) with videos related to
Sort By:
Page
of 63
CNS Spectrums
|
August 26, 2004
Augmentation strategies in the treatment of schizophrenia
D C Goff, O Freudenreich, A E Evins
Expert Review of Neurotherapeutics
|
July 6, 2007
Inflammation and schizophrenia
Xiaoduo Fan, Donald C Goff, David C Henderson
Early Intervention in Psychiatry
|
March 1, 2011
Initial medical work-up of first-episode psychosis: a conceptual review
Oliver Freudenreich, S Charles Schulz, Donald C Goff
The New England Journal of Medicine
|
April 7, 2007
Biomarkers for prediction of cardiovascular events
Diane M Becker, Samia Mora, David C Goff
Current Drug Targets. CNS and Neurological Disorders
|
May 29, 2003
Ionotropic glutamate receptors as therapeutic targets in schizophrenia
Joseph T Coyle, Guochuan Tsai, Donald C Goff
Future Cardiology
|
November 6, 2009
Atrial fibrillation and ethnicity: the known, the unknown and the paradox
Elsayed Z Soliman, Alvaro Alonso, David C Goff
North Carolina Medical Journal
|
April 27, 2013
30,000 fewer heart attacks and strokes in North Carolina: a challenge to prioritize prevention
Alain G Bertoni, Don Ensley, David C Goff
Journal of the American College of Cardiology
|
October 8, 2021
On-Treatment Hypertension Control in a Real-World Cohort: Lower Blood Pressure Remains Better
S Andrew McCullough, David C Goff, Peter M Okin
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1981
Mutation in an intervening sequence splice junction in man
S H Orkin, S C Goff, R L Hechtman
Psychopharmacology
|
July 8, 2005
The potential role of lamotrigine in schizophrenia
Charles H Large, Elizabeth L Webster, Donald C Goff
Page
of 63